title: Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level.
abstract: To our knowledge, there is little information about functional thrombin activatable fibrinolysis inhibitor (TAFI) levels and the risk of acute coronary artery disease (CAD). We investigated the risk of acute CAD related to plasma levels of functional TAFI. We found that functional TAFI levels in plasma (above 126%), increased the risk of acute CAD almost 4-fold.
authors.forename: Amparo
authors.initials: A
authors.lastname: Santamaría
authors.forename: Antonio
authors.initials: A
authors.lastname: Martínez-Rubio
authors.forename: Montserrat
authors.initials: M
authors.lastname: Borrell
authors.forename: José
authors.initials: J
authors.lastname: Mateo
authors.forename: Rosa
authors.initials: R
authors.lastname: Ortín
authors.forename: Jordi
authors.initials: J
authors.lastname: Fontcuberta
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D025901:Carboxypeptidase B2 / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood* / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D025901:Carboxypeptidase B2